Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)

Jie Liu(Army Medical University), Tarja Malm(University of Eastern Finland), Andrew N. Clarkson(Brain Research New Zealand), Jianping Jia(Beijing Friendship Hospital), Johannes Boltze(Fraunhofer Institute for Cell Therapy and Immunology), Jin‐Tai Yu(Fudan University), YuHong Fu(The University of Sydney), Heleen van Beusekom(Erasmus MC), Marietta Zille(MIND Research Institute), Lize Xiong(Jilin University), Yajie Liang(University of Maryland, Baltimore), Xuan-Yue Wang(UNSW Sydney), Pedro Ramos‐Cabrer(CIC biomaGUNE), Xin‐Fu Zhou(Flinders University), Xiaobo Mao(Johns Hopkins University), Paula Korhonen(University of Eastern Finland), Woojin S. Kim(The University of Sydney), Jukka Jolkkonen(University of Eastern Finland), Piotr Walczak(Johns Hopkins University), Colin L. Masters(Mental Health Research Institute), Yan‐Jiang Wang(Army Medical University), Karsten Ruscher(Institute of Experimental Endocrinology of the Slovak Academy of Sciences), Paulo Henrique Rosado-de-Castro(Universidade Federal do Rio de Janeiro), Xian‐Le Bu(Army Medical University), Joaquím M. Oliveira(University of Minho), Yi Yang(First Bethune Hospital of Jilin University), Weihong Song(Wenzhou Medical University), Shen Li(Universität Hamburg), Guiyou Liu(Chinese Academy of Sciences), Keqiang Ye(Shenzhen University Health Science Center), Michel Modo(King's College London), Yuhui Liu(Army Medical University), Yun Wang(Peking University), Jun Wang(Army Medical University), Gong Chen(Pennsylvania State University), Xiaowei Chen(Jingning County People's Hospital), Xiaochun Chen(Fujian Medical University), Guanghui Liu(Capital Medical University), Xunming Ji(Beijing Shijitan Hospital), Tracy D. Farr(University of Nottingham), Haitao Wu(Beijing Institute of Education)
Neuroprotection/Neuroprotection (Chichester, England. Print)
September 21, 2023
Cited by 23


Related Papers